Table S3. List of 924 transcripts/genes differentially expressed (fold change > orâ=â2, Benjamini-Hockberg corrected P value <â0.05) in internal jugular vein wall of MS patients (MS-IJW) compared to non-MS controls (C-IJW). (XLSX 207 kb
Table S2. Gene expression changes in R-EAE (E) and TMEV-IDD (T) versus their respective age-matched ...
PCR primers used to verify gene expression of SNP-containing regions of the indicated genes in whole...
Table S1. Demographic and clinical characteristics of the MS patients with benign and aggressive dis...
Table S5. List of genes, differentially expressed in MS jugular vein walls (MS-IJW) compared to cont...
Table S6. Plasma protein levels in the 2nd MS population according to clinical phenotypes. (DOCX 18 ...
Table S1. Demographics and clinical characteristics of the 2nd study MS population. (DOCX 16 kb
Background: Multiple sclerosis (MS) is an inflammatory, demyelinating and degenerative disorder of t...
BACKGROUND: Multiple sclerosis (MS) is an inflammatory, demyelinating and degenerative disorder of ...
Table S2. Comparison of fold change of protein phosphorylation between MS patients and controls afte...
Table S3. Comparison of levels of phosphorylated proteins between MS patients and controls after in ...
Additional file 1: Table S1. Proteins from CD4+ T cells differentially expressed in MS patients and ...
Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Additional file 2: Table S2. Proteins from CD8+ T cells differentially expressed in MS patients and ...
Table S3. Subclusters of genes/probes showing the most differential expression patterns between TMEV...
Table S2. Gene expression changes in R-EAE (E) and TMEV-IDD (T) versus their respective age-matched ...
PCR primers used to verify gene expression of SNP-containing regions of the indicated genes in whole...
Table S1. Demographic and clinical characteristics of the MS patients with benign and aggressive dis...
Table S5. List of genes, differentially expressed in MS jugular vein walls (MS-IJW) compared to cont...
Table S6. Plasma protein levels in the 2nd MS population according to clinical phenotypes. (DOCX 18 ...
Table S1. Demographics and clinical characteristics of the 2nd study MS population. (DOCX 16 kb
Background: Multiple sclerosis (MS) is an inflammatory, demyelinating and degenerative disorder of t...
BACKGROUND: Multiple sclerosis (MS) is an inflammatory, demyelinating and degenerative disorder of ...
Table S2. Comparison of fold change of protein phosphorylation between MS patients and controls afte...
Table S3. Comparison of levels of phosphorylated proteins between MS patients and controls after in ...
Additional file 1: Table S1. Proteins from CD4+ T cells differentially expressed in MS patients and ...
Table S4. Comparison of levels of p38MAPK, Erk1/2, STAT1, and STAT6 between MS patients and controls...
Table S1. Comparison of levels of phosphorylated proteins between MS patients and controls in baseli...
Additional file 2: Table S2. Proteins from CD8+ T cells differentially expressed in MS patients and ...
Table S3. Subclusters of genes/probes showing the most differential expression patterns between TMEV...
Table S2. Gene expression changes in R-EAE (E) and TMEV-IDD (T) versus their respective age-matched ...
PCR primers used to verify gene expression of SNP-containing regions of the indicated genes in whole...
Table S1. Demographic and clinical characteristics of the MS patients with benign and aggressive dis...